|
Pressure BioSciences, Inc Provides Update on Recent Equity Transactions
IT Business Net In consideration for the warrant holders exercising their outstanding warrants, the Company agreed to reduce the exercise price to $0.25 per warrant share. In addition, for each warrant exercised, the … Each unit consists of (i) one share of Series K … |
